ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation

Introduction Administration of intravenous (IV), high-efficacy treatments (HETs) for the treatment of multiple sclerosis (MS) poses a high resourcing and planning burden on infusion centres, resulting in treatment delays that may increase the risk of breakthrough disease activity. Simulation tools c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics - Open 2024-09, Vol.8 (5), p.755-764
Hauptverfasser:	Nicholas, Richard, Scalfaro, Erik, Dorsey, Rachel, Angehrn, Zuzanna, Banhazi, Judit, Brennan, Roisin, Adlard, Nicholas
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological products industry Business metrics Care and treatment Coronaviruses COVID-19 Decision making Development and progression Medical research Medicine Medicine & Public Health Medicine, Experimental Multiple sclerosis Neurology Nurses Oncology Original Research Article Pandemics Patients Pharmaceutical industry Pharmacoeconomics and Health Outcomes Planning Simulation Social distancing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!